We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Scotiabank
BNS
$106B
| $27.4M | 0.06% |
558,999
-848
| -0.2% | -$41.8K |
|
352
HEICO Corp Class A
HEI.A
$35.4B
| $27.3M | 0.06% |
227,646
+93,911
| +70% | +$11.5M |
|
|
KVSC
353
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $27M | 0.06% |
2,712,646
| – | – |
|
|
AAC
354
DELISTED
Ares Acquisition Corporation
AAC
| $26.9M | 0.06% |
2,674,574
-2,295,776
| -46% | -$23M |
|
355
CALL
Meta Platforms (Facebook)
META
$1.51T
| $26.8M | 0.06% |
222,300
-275,200
| -55% | -$32.3M |
|
356
Denali Therapeutics
DNLI
$3.67B
| $26.7M | 0.06% |
960,639
+284,769
| +42% | +$8.47M |
|
357
Iron Mountain
IRM
$38.2B
| $26.7M | 0.06% |
535,256
+260,985
| +95% | +$13.2M |
|
358
Akamai
AKAM
$16.8B
| $26.5M | 0.06% |
314,211
+142,752
| +83% | +$12.4M |
|
359
Lumen
LUMN
$6.53B
| $26.2M | 0.06% |
5,024,758
-6,225,131
| -55% | -$38.3M |
|
360
iShares China Large-Cap ETF
FXI
$4.31B
| $26.2M | 0.06% |
924,115
+596,476
| +182% | +$15.4M |
|
361
Silicon Motion
SIMO
$9.19B
| $26.1M | 0.06% |
401,189
+18,781
| +5% | +$1.15M |
|
|
CCVI
362
DELISTED
Churchill Capital Corp VI
CCVI
| $25.9M | 0.06% |
2,588,954
| – | – |
|
|
AYX
363
DELISTED
Alteryx Inc
AYX
| $25.8M | 0.06% |
509,819
+389,659
| +324% | +$18.6M |
|
364
Caterpillar
CAT
$409B
| $25.7M | 0.06% |
+107,329
| New | +$23.4M |
|
365
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $25.7M | 0.06% |
587,800
+32,400
| +6% | +$1.41M |
|
|
XIFR
366
XPLR Infrastructure LP
XIFR
$1.18B
| $25.7M | 0.06% |
366,380
-227,397
| -38% | -$17M |
|
|
RBCP
367
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $25.6M | 0.06% |
250,000
| – | – |
|
|
BERY
368
DELISTED
Berry Global Group, Inc.
BERY
| $25.6M | 0.06% |
461,169
+428,270
| +1,302% | +$21M |
|
369
Neogen
NEOG
$2.05B
| $25.5M | 0.06% |
1,676,792
-1,491,122
| -47% | -$21.2M |
|
370
Occidental Petroleum
OXY
$57B
| $25.5M | 0.06% |
404,994
-251,254
| -38% | -$17.1M |
|
371
TC Energy
TRP
$73.5B
| $25.5M | 0.06% |
639,352
+610,101
| +2,086% | +$26.5M |
|
372
Dick's Sporting Goods
DKS
$18.4B
| $25.5M | 0.06% |
211,770
-20,752
| -9% | -$2.34M |
|
373
Tower Semiconductor
TSEM
$26.4B
| $25.3M | 0.06% |
586,127
-108,278
| -16% | -$4.71M |
|
374
Gartner
IT
$9.41B
| $25.3M | 0.06% |
75,146
+68,806
| +1,085% | +$22.2M |
|
375
Keurig Dr Pepper
KDP
$40.4B
| $25.3M | 0.06% |
708,150
+679,799
| +2,398% | +$25.5M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.